| Diana L Turner, MD | |
|
3801 Spring St, Mount Pleasant, WI 53405-1667 | |
| (262) 687-4011 | |
| (262) 687-4280 |
| Full Name | Diana L Turner |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 22 Years |
| Location | 3801 Spring St, Mount Pleasant, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164627097 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 25686 (Nebraska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension All Saints Hospital | Racine, WI | Hospital |
| Kona Community Hospital | Kealakekua, HI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wheaton Franciscan Medical Group Inc | 8628980943 | 594 |
News Archive
A new test developed by researchers at Mayo Clinic shows which mutations in the BRCA2 gene make women susceptible to developing breast or ovarian cancers. The research behind the test was published today in the American Journal of Human Genetics.
PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat life-threatening infectious diseases and acute cardiovascular disorders, presented new clinical and pre-clinical data related to the safety and efficacy of its novel, lead defensin-mimetic antibiotic, PMX-30063.
Misuse of prescription pain medications remains a major public health problem - but programs to prevent it may be underused, according to a study in the July issue of the Journal of Studies on Alcohol and Drugs.
Surefire Medical, Inc., developer of a new class of infusion systems designed to maximize direct-to-tumor drug delivery, announced today that the company has received 510(k) FDA clearance and the CE Mark for its enhanced line of Surefire Guiding Catheters used in radioembolization and chemoembolization procedures.
› Verified 5 days ago
| Entity Name | Ascension Medical Group-southeast Wisconsin Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609881077 PECOS PAC ID: 8628980943 Enrollment ID: O20031104000421 |
News Archive
A new test developed by researchers at Mayo Clinic shows which mutations in the BRCA2 gene make women susceptible to developing breast or ovarian cancers. The research behind the test was published today in the American Journal of Human Genetics.
PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat life-threatening infectious diseases and acute cardiovascular disorders, presented new clinical and pre-clinical data related to the safety and efficacy of its novel, lead defensin-mimetic antibiotic, PMX-30063.
Misuse of prescription pain medications remains a major public health problem - but programs to prevent it may be underused, according to a study in the July issue of the Journal of Studies on Alcohol and Drugs.
Surefire Medical, Inc., developer of a new class of infusion systems designed to maximize direct-to-tumor drug delivery, announced today that the company has received 510(k) FDA clearance and the CE Mark for its enhanced line of Surefire Guiding Catheters used in radioembolization and chemoembolization procedures.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Diana L Turner, MD 3801 Spring St, Mount Pleasant, WI 53405-1667 Ph: (262) 687-4011 | Diana L Turner, MD 3801 Spring St, Mount Pleasant, WI 53405-1667 Ph: (262) 687-4011 |
News Archive
A new test developed by researchers at Mayo Clinic shows which mutations in the BRCA2 gene make women susceptible to developing breast or ovarian cancers. The research behind the test was published today in the American Journal of Human Genetics.
PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat life-threatening infectious diseases and acute cardiovascular disorders, presented new clinical and pre-clinical data related to the safety and efficacy of its novel, lead defensin-mimetic antibiotic, PMX-30063.
Misuse of prescription pain medications remains a major public health problem - but programs to prevent it may be underused, according to a study in the July issue of the Journal of Studies on Alcohol and Drugs.
Surefire Medical, Inc., developer of a new class of infusion systems designed to maximize direct-to-tumor drug delivery, announced today that the company has received 510(k) FDA clearance and the CE Mark for its enhanced line of Surefire Guiding Catheters used in radioembolization and chemoembolization procedures.
› Verified 5 days ago
Carlos R Galvao-sobrinho, MD, PHD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3805b Spring St Ste 260, Mount Pleasant, WI 53405 Phone: 262-687-8340 Fax: 262-687-8365 | |
Dr. Ubaid Nawaz, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 8400 Washington Ave Ste 203, Mount Pleasant, WI 53406 Phone: 262-884-8340 | |
Alexandra Beris, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3801 Spring St, Mount Pleasant, WI 53405 Phone: 262-687-4011 | |
Dr. Dajun Wang, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 13250 Washington Ave, Mount Pleasant, WI 53177 Phone: 888-720-2012 | |
Jonathan Rathod, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 3803 Spring St, Mount Pleasant, WI 53405 Phone: 262-687-5236 | |
Dr. Boby G Theckedath, M.D Internal Medicine Medicare: Medicare Enrolled Practice Location: 8400 Washington Ave, Mount Pleasant, WI 53406 Phone: 262-884-4000 Fax: 262-884-4177 |